Rhenman & Partners Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$1.02M | – | 97 |
|
|
2019
Q2 | $1.02M | Buy |
+10,000
| New | +$1.02M | 0.11% | 75 |
|
|
2019
Q1 | – | Sell |
-88,302
| Closed | -$3.46M | – | 100 |
|
|
2018
Q4 | $3.46M | Sell |
88,302
-49,389
| -36% | -$1.93M | 0.4% | 64 |
|
|
2018
Q3 | $7.51M | Sell |
137,691
-39,909
| -22% | -$2.18M | 0.75% | 53 |
|
|
2018
Q2 | $14.7M | Buy |
177,600
+110,000
| +163% | +$9.1M | 1.5% | 30 |
|
|
2018
Q1 | $4.5M | Sell |
67,600
-2,600
| -4% | -$173K | 0.55% | 58 |
|
|
2017
Q4 | $3.61M | Buy |
+70,200
| New | +$3.61M | 0.49% | 64 |
|